VA Innovation Awardees Include Projects to Reduce Adverse Drug Reactions

By Jeff Rowe
10:58 AM
Share

On May 6, the U.S. Department of Veterans Affairs (VA) announced the second round of awards from the agency’s Industry Innovation Competition. Five pilot projects will receive funding from the VA Innovation Initiative (VAi2). Among the awarded projects, two are related to electronic patient data.

On May 6, the U.S. Department of Veterans Affairs (VA) announced the second round of awards from the agency’s Industry Innovation Competition. Five pilot projects will receive funding from the VA Innovation Initiative (VAi2). Among the awarded projects, two are related to electronic patient data.
Through an award to DSS, Inc. of Juno Beach, Fla., and TheraDoc of Salt Lake City, a pilot at five VA medical centers in Texas, Missouri and Illinois will use clinical and laboratory data in real time to identify patients at risk of adverse drug reactions.
VAi2 made another award in the area of adverse drug effects to the Southwest Research Institute, a not-for-profit group based in San Antonio. The project will enable clinicians at the Cincinnati VA Medical Center to integrate clinical and laboratory data to predict which patients are at risk of adverse drug reactions.
VAi2 selects, funds and evaluates new ideas from VA employees, academia and the private sector for the Industry Innovation Competition. The awards announced May 6 were the first to involve the private sector. The next round of awards will be announced in a few weeks, according to the VA.
The Innovation Competition seeks ideas to address the following VA challenges:
  • developing next-generation telehealth solutions;
  • improving polytrauma care;
  •  preventing adverse drug events;
  • finding new models of care for dialysis and chronic kidney disease;
  • enabling Veteran entrepreneurship through Business Accelerator services; and
  • deploying housing solutions to reduce Veteran homelessness.
Click here for more information on the competition.
Photo by thomasbrightbill courtesy of Creative Commons license.